Accelerating Precision Medicine through Innovation
Accelerating Precision Medicine through Innovation
The realization of personalized medicine is upon us as more and more cancers can be classified on their genetic signatures. These subtypes can be targeted with tailored treatments that more effectively can combat the cancer and possibly reduce the overall side effects. The most reliable material to test a potential treatment compound is an actual sample of fresh tumor. Needle core biopsies are usually the first choice in acquiring tissue for diagnosis.
A dual needle core biopsy instrument that can take two samples directly adjacent to each other guarantees homogeneity of the samples. One would be sent for microscopic diagnostic evaluation while the other would be submitted for genetic studies. The instrument will also ensure that only diagnostic tissue would be sent for the more expensive molecular testing. If the tumor tissue was not represented by microscopy, the testing would not be processed.
We love our customers, so feel free to visit during normal business hours.
Mon | 09:00 am – 05:00 pm | |
Tue | 09:00 am – 05:00 pm | |
Wed | 09:00 am – 05:00 pm | |
Thu | 09:00 am – 05:00 pm | |
Fri | 09:00 am – 05:00 pm | |
Sat | Closed | |
Sun | Closed |
Get 10% off your first purchase when you sign up for our newsletter!
We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data.